The topical corticosteroid scalp treatment is expected to return to pharmacies in late February 2020.
Following ongoing availability issues with the potent topical corticosteroid scalp treatment, Bettamousse 0.1% Cutaneous Foam (betamethasone valerate), the manufacturer, RPH Pharmaceuticals AB, contacted us with an update in February 2020.
RPH confirmed that new stocks of Bettamousse Foam are due to arrive by the end of February, following some challenges with transport to the UK from its manufacturing site in Switzerland. As such, Bettamousse is expected to return to stock in late February 2020.
If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0845 023 0467, or by email at email@example.com.
You can find more information about other currently unavailable treatments here